These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25968124)

  • 21. [Arterial Hypertension - when are which combination therapies useful?].
    Brenner R; Rimoldi SF; Rexhaj E; Allemann Y
    Ther Umsch; 2012 May; 69(5):305-13. PubMed ID: 22547363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in the elderly: a patient case study.
    Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():22A-24A. PubMed ID: 10205253
    [No Abstract]   [Full Text] [Related]  

  • 24. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
    Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swedish hypertension open care retrospective study in men and women (SHOW).
    Ljungman C; Collén AC; Manhem K
    J Hum Hypertens; 2011 Jan; 25(1):32-7. PubMed ID: 20410917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.
    Thoenes M; Neuberger HR; Volpe M; Khan BV; Kirch W; Böhm M
    J Hum Hypertens; 2010 May; 24(5):336-44. PubMed ID: 19798089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pressor responses to antihypertensive drug types.
    Alderman MH; Cohen HW; Sealey JE; Laragh JH
    Am J Hypertens; 2010 Sep; 23(9):1031-7. PubMed ID: 20725055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
    Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
    Takenaka T; Uchida K; Kojima E; Gen S; Nodaira Y; Hoshi H; Kato N; Takane H; Ohno Y; Suzuki H
    Clin Exp Hypertens; 2011; 33(4):210-5. PubMed ID: 21699446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.
    Bajraktari G; Sylejmani X; Thaçi K; Elezi S; Ndrepepa G
    Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
    Shabalin AV; Nikitin IuP
    Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical-epidemological study of drugs used to treat arterial hypertension and associated comorbidities.
    Leon MM; Mitu F
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):488-94. PubMed ID: 24340535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.